ArticleScientific reports2022

Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study.

Sanji Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.